title: Is the use of topical vancomycin to prevent mediastinitis after cardiac surgery justified?
authors.forename: R E
authors.initials: RE
authors.lastname: Oakley
authors.forename: K A
authors.initials: KA
authors.lastname: Nimer
authors.forename: E
authors.initials: E
authors.lastname: Bukhari
mesh_terms: D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002315:Cardiopulmonary Bypass; D006801:Humans; D008480:Mediastinitis / Q000382:microbiology / Q000517:prevention & control*; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control*; D013530:Surgical Wound Infection / Q000517:prevention & control*; D014640:Vancomycin / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin